Ariel López-Chávez - Researcher Profile

Publications

2 shown

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Mark A. Socinski , Robert M. Jotte , Federico Cappuzzo +17 more

The addition of atezolizumab to bevacizumab plus chemotherapy significantly improved progression-free survival and overall survival among patients with metastatic nonsquamous NS...

2018 New England Journal of Medicine 3592 citations

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi , Julien Mazières , David Planchard +27 more

2015 The Lancet Oncology 1406 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,998
Institution: Sylvester Comprehensive Cancer Center

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.